Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062406) titled 'Clinical importance of Helicobacter suis infection and gastric microbiota in patients received medical health check-ups:
An International collaborative prospective observational study' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Oita University
Condition:
Condition - H. suis infectious disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study was designed to compare the prevalence of H. suis infection in Japan and Korea among individuals received endoscopy. The study aims to identify factors contributing to H. suis infection, clarify its association with the development of GI diseases, and investigate its relationship with the gastric microbiota through an international, multicenter, prospective study.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - (1) Individuals aged 20 or older who scheduled to receive an EGD for check-ups by March 31, 2028
(2) Individuals who have provided written informed consent to participate
Key exclusion criteria - (1) Individuals whose H. pylori infection status is unknown
(2) Individuals who have had gastric surgical treatment
(3) Individuals who have taken antimicrobial agents within two weeks
(4) Individuals whom the research staff deem unsuitable
Target Size - 1000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 09 Month 28 Day
Anticipated trial start date - 2026 Year 10 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071419
Disclaimer: Curated by HT Syndication.
